M uch progress has been made since Barker and colleagues first proposed that conditions in utero influence the susceptibility to disease later in life. 1 The association between fetal growth retardation and adult hypertension, cardiovascular disease and diabetes mellitus has been established by extensive epidemiology. 2, 3 It has also been recognized that in order to prevent pathogenic programming we need to identify and target specific maternal factors or conditions, and that maternal overnutrition, rather than undernutrition, is prevalent in the Western world. Several such factors have already been established (eg, maternal hypercholesterolemia, 4 -6 smoking, 7 and diabetes mellitus 8 ) and experimental models have been developed in which mechanisms and causal relationships of developmental programming can be investigated. Finally, the influence of maternal or environmental factors on adult disease is now widely accepted, and the expectation of a wave of cardiovascular disease in children of obese, hyperlipidemic, and diabetic mothers has led the US Congress and the National Institutes of Health to place great emphasis on the elucidation of specific risk factors (eg, in the National Children's Study 9 ). Animal models are key to identifying the mechanisms involved and finding preventive approaches that go beyond simple avoidance of risk during pregnancy or treatment of maternal dysmetabolic conditions.
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In this regard, hypertension and stroke lag far behind. Although hypertension is a major risk factor of cardiovascular disease in adults, and fetal exposure to high salt concentrations promotes hypertension in offspring in both saltsensitive and resistant rat strains, 10, 11 most of what we know about in utero modulation of hypertensive mechanisms comes from models of maternal hypercholesterolemia or obesity rather than hypertension. For example, maternal hypercholesterolemia and the ensuing increased oxidative stress not only promote atherogenesis but affect endothelial function, probably by interfering with nitric oxide-mediated vascular relax-ation. [12] [13] [14] Furthermore, endothelial dysfunction often did not translate into postnatal hypertension, much less stroke. More importantly, although a plethora of models of adult stroke exists, none of these is spontaneous, and they are therefore not useful for investigating the developmental programming of stroke. Induction of stroke in established models depends on deliberate intervention, such as ligature of the middle cerebral artery by way of the external carotid artery, occlusion of smaller-caliber cerebral arteries by transcranial surgery or injection of microspheres, injection of exogenously generated thrombi, or radiation damage to vascular endothelia and surrounding brain tissue. 15 An article by Decano et al in this issue of Circulation not only describes the first model of spontaneous stroke but also provides important new insights into the role of early-life risk factors in general. 16 In an earlier article, Herrera and colleagues had generated 4 transgenic lines of Dahl salt-sensitive (Dahl-S) rats expressing human cholesterol-ester transfer protein (CETP) under control of the human apolipoprotein CIII promoter. 17 As anticipated, human CETP transgenic (Tg) rats developed hypercholesterolemia, hypertriglyceridemia, and hypertension, even on relatively low-salt diets, as well as carotid and coronary atherosclerosis. Males of the transgenic line with the greatest CETP expression, Tg53, showed severe combined hyperlipidemia with cholesterol Ͼ800 mg/dL and not only extensive atherosclerosis but also coronary thrombosis, myocardial infarctions, and decreased survival, despite developing lower systolic pressure than non-Tg Dahl-S controls. The main conclusion of this article was that CETP is proatherogenic, in contrast to the results of several studies in CETPtransgenic mice and, apparently, the failure of a CETP inhibitor in a recent clinical trial. 18 In the current study by Decano and colleagues, 16 a line with less extensive human CETP expression and more moderate hyperlipidemia (Tg25) was selected to investigate the atherogenic effect of early-life hypertension induced by a moderate salt concentration (0.4% NaCl instead of 0.23% in regular rat chow, which does not cause hypertension in the Dahl-S strain). Tg25 rats were chosen because they were anticipated to develop less atherosclerosis and therefore to have a longer lifespan than theTg53 strain. Salt exposure began during fetal development (by maternal administration throughout pregnancy and lactation), after weaning at 3 weeks, or at the young-adult age of 8 weeks (Figure) . Unexpectedly, early-life salt exposure resulted in a dramatic increase in strokes. All offspring exposed during fetal development and lactation, and 70% to 100% of offspring exposed after weaning, but only 30% of those exposed as adults, developed neurological signs of stroke, such as seizures, paresis, or paralysis. Females were more affected than males, although both sexes showed similar systolic blood pressure, perhaps because their relative increase in blood pressure, compared with animals fed regular chow, was much greater than that of males. Death occurred after Ϸ100 to 130 days in animals exposed in utero, 120 to 180 days in those exposed at weaning, and 260 days in females exposed as adults. In contrast, strokes were absent or minimal, respectively, in chow-fed male and female controls. Thus, stroke mortality was greatly increased by early-life dietary salt, even though adults were exposed for much longer.
A detailed and technically excellent characterization of the model revealed acute hemorrhages and microhemorrhages with active neutrophil transmigration and consistent expression of adhesion molecules, as well as subacute hemorrhages characterized by hemorrhagic-necrotic areas rich in inflammatory cells. Ex vivo magnetic resonance imaging of stroke brains confirmed that hemorrhages and functional damage were localized mainly in cortical and subcortical areas supplied by the middle cerebral artery but did not affect the cerebellum. Interestingly, reduced microvascularization and neuronal ischemia in the affected areas were already seen before neurological stroke manifestation. Ultrasound microimaging detected carotid artery disease that may have contributed to embolic occlusion of the middle cerebral artery or its branches. Thus, the model displays many features of human ischemic stroke with hemorrhagic transformation (eg, cortical hemor-rhagic infarctions, microhemorrhages, neuronal ischemia, and microvascular injury). It is consistent with the concept of evolving stroke damage and may reflect the transformation from ischemic to hemorrhagic stroke in humans, in particular its microvascular injuries. On the other hand, notable differences remain with regard to the size, rapid progression, and lethality of strokes, which are reminiscent of the relatively infrequent (Ͻ10%) malignant strokes of humans, in which a large affected area leads to progressive infarct expansion and death. 15 Furthermore, the complete absence of cerebellar involvement is inconsistent with hypertensive strokes in humans. In terms of causality, the model does reflect the combination of hyperlipidemia and hypertension prevalent in humans, but one has to remember that CETP is extraneous to lipoprotein metabolism in rats or mice, that Dahl-S rats are also insulin resistant, which is not the case for many stroke patients, and that their genetic sensitivity to salt may be greater than that of most humans. Despite these weaknesses, the availability of a model of spontaneous stroke, where none existed previously, is a huge step forward.
The marked effect of early salt exposure on stroke manifestation also prompts some reflection on the pathogenic role of early-life risk factors in general and developmental programming in particular. For some forms of developmental programming (eg, by impaired fetal growth), programming may be limited to fetal development and risk factors exacerbating adult disease may differ from those affecting the fetus. However, the literature suggests that for many factors pro- gramming offspring disease susceptibility, such as maternal hypercholesterolemia, smoking, and diabetes mellitus, the intrauterine and lactation period represent a continuity. Whether such programming occurs in the present model is not established. In fact, several mechanisms may account for the present observations (Figure) .
If we assume that the pathogenic challenge exerted by the combination of hyperlipidemia, salt exposure, and genetic susceptibility is the same, irrespective of the time of onset, 3 mechanisms may account for earlier and more severe strokes in animals exposed during early life. First, it is possible that fetuses and neonates/infants are particularly vulnerable, but that the pathogenic mechanisms leading to stroke are essentially the same as those affecting adults. This would be analogous to the increased sensitivity of children to drugs and environmental toxins and would not require programming.
Second, it is possible that early-life exposure to pathogenic factors leads to impaired development of tissues or organs (arterial endothelia, brain), and that persistence of such damage greatly enhances the progression to symptomatic stroke. Again, analogies exist (eg, in lungs of asthmatic children whose mothers smoked during pregnancy). Such "histological memory" would be diminished in fully developed adult tissues.
The third scenario is that postulated for most early-life risk factors (ie, "programming"). Several mechanisms potentially contributing to such programming have been reported, including persistent changes in arterial gene expression and mitochondrial DNA. Some of these may be caused by increased lipid peroxidation, which leads to protein modifications altering receptor recognition, enzymatic activities, and other biologically important functions. Hypercholesterolemia is inherently associated with increased lipid peroxidation, and increased oxidative stress may also act by interfering with multiple oxidation-sensitive nuclear signaling pathways. 4, 6, 19 However, to date it has not been proven that any of these events actually causes or contributes to increased disease manifestation in offspring.
Compared with postweaning onset, fetal salt exposure significantly enhanced stroke only in the less susceptible male mice, and even that result has to be taken with caution, because lifespan included the 3 weeks of lactation, during which only the offspring of the fetal-exposure group may have received increased salt. This would suggest that the fetal period is not unique and that fetal, as opposed to early-life, programming does not play an essential role. Nevertheless, the model includes maternal hypercholesterolemia, which does program the susceptibility to atherosclerosis in utero.
Irrespective of which of the 3 mechanisms is involved, the model emphasizes the crucial importance of the early-life period for the extent and severity of adult diseases, including end-organ diseases, and the fact that multiple pathogenic factors or mechanisms are involved. In this case, we have a combination of inherited genetic factors (salt sensitivity and CETP expression) that by themselves are insufficient to cause stroke, except perhaps by promoting atherosclerosis. Only once a third factor is added, 0.4% salt exposure, which by itself is also not pathogenic, does the balance swing all the way toward clinical manifestation. Obviously, this will com-plicate the search for pathogenic factors, because the genetic variability will have to be considered. On the other hand, preventive measures may consist of a safer combination targeting diverse risk factors, rather than aggressive treatment of just one. Finally, we will have to consider the interactions, in utero or during early life, between pathogenic and protective mechanisms. In the present model, both hypertension and atherosclerosis are likely to be enhanced by hypercholesterolemia and the ensuing oxidative stress, as is insulin resistance. Both promote inflammatory events and immune responses and may in turn be attenuated by maternal immune mechanisms. 19 Last but not least, when assessing the consequences of early-life programming, we need to be aware that they may be latent and become unmasked only by more severe risk factors later in life. 20 Clearly, a lot still needs to be done.
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